← Back to Search

Wrist Biosensor + mHealth App for HIV/AIDS (SHARE Engage Trial)

Q: Who fulfills the requirements to be eligible for this scientific research?

<p>This clinical trial is recruiting 160 <a href="https://www.withpower.com/clinical-trials/hiv">HIV</a>/<a href="https://www.withpower.com/clinical-trials/aids">AIDS</a>-positive individuals aged 18 to 29. Candidates must live in <a href="https://www.withpower.com/clinical-trials/florida">Florida</a>, have consumed alcohol at least once within the past 30 days, possess basic English literacy and internet access, be willing to sign informed consent forms and provide proof of their diagnosis.</p>

N/A

Recruiting

Research Sponsored by Florida State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be diagnosed as HIV positive and;

18 years and 0 months to 29 years and 11 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 12 hours after prompted engagement strategy

Awards & highlights

SHARE Engage Trial Summary

This trial will use a wrist alcohol biosensor & an app to track alcohol use & test two strategies to help people engage with the device.

Who is the study for?

This trial is for young people living with HIV in Florida, aged 18-29, who have had a drink in the last month. They must understand English, be able to give informed consent, and have internet access. It's not for prisoners, those unable to consent or individuals without an HIV diagnosis.Check my eligibility

What is being tested?

Participants will wear a wrist alcohol biosensor for a month and use an app to report their drinking. The study tests if 'reciprocity' (exchanging things with others) and personalized feedback through the app can increase engagement with the biosensor.See study design

What are the potential side effects?

There are no direct medical side effects mentioned as this intervention involves wearing a biosensor and using an app. However, participants may experience discomfort or inconvenience from wearing the device continuously.

SHARE Engage Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with HIV.

Select...

I am between 18 and 29 years old.

SHARE Engage Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 12 hours after prompted engagement strategy

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 12 hours after prompted engagement strategy

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 12 hours after prompted engagement strategy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Engagement in biosensor wearing

SHARE Engage Trial Design

1Treatment groups

Experimental Treatment

Group I: Engagement in biosensor wearingExperimental Treatment1 Intervention

A subset of the participants will receive the same interventions, namely the reciprocity messages, personalized feedback, or no prompt (as control condition), using micro-randomization procedure that randomly assign one of the condition in the morning and one of the condition in the evening.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor

200 Previous Clinical Trials

31,598 Total Patients Enrolled

University of FloridaOTHER

1,341 Previous Clinical Trials

715,486 Total Patients Enrolled

University of MichiganOTHER

1,798 Previous Clinical Trials

6,377,978 Total Patients Enrolled

Media Library

Engagement in biosensor wearing Clinical Trial Eligibility Overview. Trial Name: NCT05431855 — N/A

HIV/AIDS Research Study Groups: Engagement in biosensor wearing

HIV/AIDS Clinical Trial 2023: Engagement in biosensor wearing Highlights & Side Effects. Trial Name: NCT05431855 — N/A

Engagement in biosensor wearing 2023 Treatment Timeline for Medical Study. Trial Name: NCT05431855 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial extend its enrollment to individuals over 55 years of age?

"This medical trial is tailored to young adults aged between 18 and 29 years old. Conveniently, there are 76 other clinical trials for minors and 233 studies available for seniors."

Answered by AI

Are there any opportunities for enrolment in this research venture?

"Based on the information found on clinicaltrials.gov, this research is actively seeking participants; it was initially posted in February 1st 2023 and had its last update a few weeks later, in February 21st 2023."

Answered by AI

What is the upper limit for how many people can join this trial?

"Affirmative. According to clinicaltrials.gov, this research study is in the process of recruiting participants. It was first publicized on February 1st 2023 and last modified on February 21st 2023. The trial requires 160 patients from a single location for completion."

Answered by AI

Who fulfills the requirements to be eligible for this scientific research?

"This clinical trial is recruiting 160 HIV/AIDS-positive individuals aged 18 to 29. Candidates must live in Florida, have consumed alcohol at least once within the past 30 days, possess basic English literacy and internet access, be willing to sign informed consent forms and provide proof of their diagnosis."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Project Engage: A Wrist Biosensor-based mHealth Suite to Support Alcohol Intervention in Young People Living With HIV

Sylvie Naar 2023. "Project Engage: A Wrist Biosensor-based mHealth Suite to Support Alcohol Intervention in Young People Living With HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05431855.